Alan List - 26 Apr 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Medical Officer
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Alan List
Issuer symbol
DTIL
Transactions as of
26 Apr 2022
Net transactions value
-$16,328
Form type
4
Filing time
28 Apr 2022, 17:22:15 UTC
Previous filing
07 Mar 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +26,035 26,035 26 Apr 2022 Direct F1, F2
transaction DTIL Common Stock Sale $16,328 -7,775 -30% $2.10 18,260 27 Apr 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -26,035 -33% $0.000000 52,055 26 Apr 2022 Common Stock 26,035 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2022.
F2 Each RSU represents a contingent right to receive one share of the Company's Common Stock.
F3 The sale was effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4 On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

Remarks:

Exhibit List: Exhibit 24 Power of Attorney